• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于快速鉴定 Le 基因的新型基因分型方法,用于选择 CA19-9 诊断的患者。

A novel genotyping method for rapid identification of the Le gene to select patients for diagnosis with CA19-9.

机构信息

Department of Legal Medicine, Graduate School of Medicine, Gunma University, Maebashi, Japan.

Department of Innovative Cancer Immunotherapy, Graduate School of Medicine, Gunma University, Maebashi, Japan.

出版信息

Clin Chim Acta. 2023 Jan 1;538:181-188. doi: 10.1016/j.cca.2022.11.006. Epub 2022 Nov 17.

DOI:10.1016/j.cca.2022.11.006
PMID:36403666
Abstract

BACKGROUND

The antigenic determinant of CA19-9 is synthesized by the α1,3/4fucosyltransferase encoded by the Le gene in the Lewis blood group system. Accordingly, a diagnosis with CA19-9 is not appropriate forLe-negative patients who possess the Le gene-mutated le alleles homozygously.

METHODS

A Le gene-specific PCR was undertaken to determine c59T>G by using a set of tag-sense and biotin-labeled anti-sense primers and a peptide nucleic acid-le-clamp which bound to G59 in the le alleles. Following mixing with streptavidin-coatedbluelatex beads, the PCR products were developed on a strip on which the complementary tag oligonucleotide to theLe gene-specific amplicon was immobilized.

RESULTS

When the PCR products were developed on the strip, a clear line was rapidly observed in Le-positive but not in Le-negative individuals. In contrast, a significant number of cancer patients with Lewis-negative phenotype were found to possess CA19-9, while they were specifically genotyped asLe/-. No contradictory results were observed in cancer patients (n = 315) with respect to their Lewis genotypes and CA19-9 levels.

CONCLUSIONS

c59T>G occurred commonly in the le alleles could be specifically and rapidly identified by the present method. This method appeared to be relevant forselecting cancer patientsto bediagnosed with CA19-9.

摘要

背景

CA19-9 的抗原决定簇由 Lewis 血型系统中 Le 基因编码的 α1,3/4 岩藻糖基转移酶合成。因此,对于具有 Le 基因突变等位基因纯合子的 Le 阴性患者,CA19-9 诊断并不合适。

方法

采用一组标记 sense 和生物素标记 anti-sense 引物以及与 le 等位基因中 G59 结合的肽核酸-Le-夹,进行 Le 基因特异性 PCR,以确定 c59T>G。将 PCR 产物与链霉亲和素包被的蓝色乳胶珠混合后,在一条带有 Le 基因特异性扩增子互补标记寡核苷酸的条带上进行开发。

结果

当 PCR 产物在条带上进行开发时,Le 阳性个体中迅速观察到清晰的线条,但 Le 阴性个体中则没有。相比之下,许多Lewis 阴性表型的癌症患者被发现具有 CA19-9,但它们被特异性地鉴定为 Le/ -。在具有 Lewis 基因型和 CA19-9 水平的癌症患者(n=315)中未观察到相反的结果。

结论

本方法可特异性、快速地鉴定出 Le 等位基因中常见的 c59T>G。该方法似乎与选择癌症患者进行 CA19-9 诊断有关。

相似文献

1
A novel genotyping method for rapid identification of the Le gene to select patients for diagnosis with CA19-9.一种用于快速鉴定 Le 基因的新型基因分型方法,用于选择 CA19-9 诊断的患者。
Clin Chim Acta. 2023 Jan 1;538:181-188. doi: 10.1016/j.cca.2022.11.006. Epub 2022 Nov 17.
2
Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients.Lewis和分泌型基因剂量影响正常个体及结直肠癌患者的CA19-9和DU-PAN-2血清水平。
Cancer Res. 1998 Feb 1;58(3):512-8.
3
Investigation of unexpected serum CA19-9 elevation in Lewis-negative cancer patients.Lewis 阴性癌症患者血清 CA19-9 升高的意外调查。
Ann Clin Biochem. 2012 May;49(Pt 3):266-72. doi: 10.1258/acb.2011.011213. Epub 2012 Apr 5.
4
Molecular genetic analysis of the human Lewis histo-blood group system.人类Lewis组织血型系统的分子遗传学分析
J Biol Chem. 1994 Nov 18;269(46):29271-8.
5
Smoking and serum CA19-9 levels according to Lewis and secretor genotypes.根据Lewis和分泌型基因分型的吸烟情况与血清CA19-9水平
Int J Cancer. 2008 Dec 15;123(12):2880-4. doi: 10.1002/ijc.23907.
6
The relationship between Lewis/Secretor genotypes and serum carbohydrate antigen 19-9 levels in a Korean population.韩国人群中Lewis/分泌型基因型与血清糖类抗原19-9水平的关系。
Korean J Lab Med. 2010 Feb;30(1):51-7. doi: 10.3343/kjlm.2010.30.1.51.
7
Divergence in phenotyping and genotyping analysis of the Lewis histo-blood group system.Lewis 组织血型系统表型和基因型分析中的差异。
Transfus Med. 2021 Apr;31(2):129-135. doi: 10.1111/tme.12756. Epub 2021 Jan 11.
8
Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.根据Lewis血型和分泌型血型基因型组合分类的膀胱癌患者尿CA19-9水平的评估
Int J Urol. 2007 Sep;14(9):795-9. doi: 10.1111/j.1442-2042.2007.01840.x.
9
Genetic evidence for the Lewis enzyme, which synthesizes type-1 Lewis antigens in colon tissue, and intracellular localization of the enzyme.在结肠组织中合成1型Lewis抗原的Lewis酶的遗传学证据以及该酶的细胞内定位。
Cancer Res. 1996 Jan 15;56(2):330-8.
10
Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels.部分血清CA19-9水平较高的癌症患者红细胞上Lewis抗原表达缺失。
J Natl Cancer Inst. 1987 Dec;79(6):1261-8.

引用本文的文献

1
α-Acid Glycoprotein with Highly Fucosylated Glycans as a Potential Diagnostic Marker for Early Detection of Hepatobiliary and Pancreatic Cancers.具有高度岩藻糖基化聚糖的α-酸性糖蛋白作为肝胆胰癌早期检测的潜在诊断标志物
Diagnostics (Basel). 2024 Dec 27;15(1):40. doi: 10.3390/diagnostics15010040.